Eduardo Schur serves as a Partner in the EY Life Sciences Practice and leads the Health Sciences & Wellness Commercial Practice. He brings over 30 years of experience in the Pharmaceutical and Medical Device markets. His expertise includes strategic planning, market assessments, and multiple product launches across many therapeutic areas. Prior to joining EY, he was the Global Leader of the Guidehouse (Navigant) Life Sciences Practice and Vice President of Marketing at Bristol-Myers Squibb where he held several commercial leadership positions. Eduardo began his healthcare career with Johnson & Johnson. He is currently part of the faculty at Rutgers University, Edward J. Bloustein School of Planning and Public Policy.

In recent years Eduardo has been involved in Life Science projects spanning numerous therapeutic areas including: Oncology, Immunology, Depression, Anxiety, Alzheimer’s Disease, Parkinson’s Disease, Pain, Multiple Sclerosis, Insomnia, Schizophrenia, Stroke, Acute Coronary Syndrome, Peripheral Arterial Disease, Angina, Hypertension, Deep Vein Thrombosis, Atrial Fibrillation, Diabetes, Psoriasis, Fungal Infections, Dyspepsia, Gastric Paresis and Oral Contraceptives (Women’s Healthcare).

Key areas of expertise are: Market Assessments, Brand and Marketing Strategy Development, Competitive Assessment, Analysis of Patient Pathways (Journey) and Buying Process, Positioning, Segmentation, Portfolio and Franchise Strategy, Licensing, Partnering and Acquisition Strategies, New Product Planning, Market Analytics and Customer Insights.